Caas Capital Management LP Bio N Tech Se Transaction History
Caas Capital Management LP
- $895 Million
- Q1 2025
A detailed history of Caas Capital Management LP transactions in Bio N Tech Se stock. As of the latest transaction made, Caas Capital Management LP holds 17,190 shares of BNTX stock, worth $1.68 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
17,190
Previous 17,190
-0.0%
Holding current value
$1.68 Million
Previous $1.96 Million
20.07%
% of portfolio
0.17%
Previous 0.35%
Shares
8 transactions
Others Institutions Holding BNTX
# of Institutions
340Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$796 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$415 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$395 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$185 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$176 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $23.7B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...